A rational approach to the development of antiviral chemotherapy: alternative substrates of herpes simplex virus Type 1 (HSV-1) and Type 2 (HSV-2) thymidine kinase (TK).
D000998:Antiviral Agents / Q000378:metabolism* / Q000494:pharmacology; D011741:Pyrimidine Nucleosides / Q000378:metabolism / Q000494:pharmacology; D018139:Simplexvirus / Q000187:drug effects / Q000201:enzymology*; D013937:Thymidine Kinase / Q000378:metabolism*
D000998:Antiviral Agents; D011741:Pyrimidine Nucleosides; D013937:Thymidine Kinase